- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05337722
App for Pregnancy Smoking Cessation With Peer Support (SFT)
A Smartphone Intervention for Pregnancy Smoking Cessation With Peer Support
The objectives of this project are to develop, implement, and test the feasibility and effectiveness of an artificial intelligence adaptive mobile pregnancy tobacco cessation app-based intervention using deep tailoring and a self-nominated support person, and to build mHealth research capacity in Romania. The central hypothesis is that the intervention will show evidence of feasibility and effectiveness in increasing positive support, pregnancy cessation, and postnatal abstinence. The intervention is grounded in Self-Determination Theory (SDT) and Motivational Interviewing (MI), a counselling style that is effective in assisting people to quit smoking. The app will be novel in its use of the unique functionality of smartphones, use of reinforcement learning (RL) and deep tailoring to continuously adapt the intervention, the emphasis on increasing positive support, and the use of the app by both smoker and support person. The long-term goal of the research program is to use mHealth for smoking cessation leveraging the unique functionality of smartphones and to continue building mHealth research capacity and developing research networks in Central and Eastern Europe (CEE) and other LMICs.
Aim 1 (R21 phase). Develop and test the feasibility and acceptability of the SFT2.0 app-based mobile smoking cessation intervention with a support person during pregnancy and postpartum in Romania. Through a user-centered and iterative design the investigators will enhance the SFT1.0 app, deepen the tailoring, incorporate RL, expand the app for use by any support person, and test the intervention including the app and MI video counseling in a series of usability studies and a 12-week open trial (n=20).
Aim 2 (R33 phase). Test the SFT2.0 app-based smoking cessation intervention in a hybrid effectiveness and implementation randomized controlled trial. The investigators will randomize 375 pregnant smokers and their support persons to i) a fixed arm, including the SFT2.0 app for both, and fixed pre- and postnatal MI counseling; ii) an RL-adaptive arm, with the app continuously optimizing as-needed MI counseling; or iii) control group.
Aim 3 (R21 and R33 phases). Develop mHealth research capacity by enhancing individual and institutional research capabilities in Romania and expanding the existing international research network.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Cristian I Meghea, PhD
- Phone Number: 2487161043
- Email: meghea@msu.edu
Study Contact Backup
- Name: Oana M Blaga
- Phone Number: +40 749240017
- Email: oana.blaga@ubbcluj.ro
Study Locations
-
-
Cluj
-
Cluj-Napoca, Cluj, Romania, 400301
- Recruiting
- Babes-Bolyai University
-
Contact:
- Marina Dascal
- Phone Number: +40 753 990 297
- Email: marina.dascal@publichealth.ro
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- age>=18
- pregnant
- user of regular cigarettes
- availability of Android phone with broadband data
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: App+fixed MI
The participants will use the SFT2.0 app and receive a fixed number of 4 counseling video sessions during pregnancy up to 1-month postpartum.
|
The SFT 2.0 intervention will include the use of the SFT 2.0 smoking cessation app, Motivational Interviewing (MI) counseling, and the support of a peer person
|
|
Experimental: Adaptive app + as-needed MI
The participants will use the SFT2.0 app and receive as-needed prenatal and postnatal video counseling sessions (between 1 and 10 sessions) during pregnancy up to 1-month postpartum.
|
The SFT 2.0 intervention will include the use of the SFT 2.0 smoking cessation app, Motivational Interviewing (MI) counseling, and the support of a peer person
|
|
Active Comparator: Control
Participants will receive low dose prenatal and postnatal MI video counseling, defined as one prenatal session and one postnatal session.
|
Low dose prenatal and postnatal MI video counseling, defined as one prenatal session and one postnatal session
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in smoking cessation
Time Frame: 3 and 6 months after birth
|
7-day point biochemically verified prevalence of tobacco use
|
3 and 6 months after birth
|
|
Change in postpartum abstinence
Time Frame: 3 and 6 months after birth
|
Fewer than 5 cigarettes smoked since birth
|
3 and 6 months after birth
|
|
Reach
Time Frame: 1 month after birth
|
Proportion and representativeness (e.g., age, ethnicity) of dyads who enroll in each trial arm compared to each other and the general population of pregnant women in Romania
|
1 month after birth
|
|
Adoption
Time Frame: 1 month after birth
|
Proportion of participants who enroll in SFT2.0 by recruitment strategy
|
1 month after birth
|
|
Implementation
Time Frame: 1 month after birth
|
Participants frequency of overall SFT2.0 use and of the different app components
|
1 month after birth
|
|
User engagement
Time Frame: 1 month after birth
|
quality of the user experience when interacting with SFT2.0 measured using the four constructs of the User Engagement Scale short form: focused attention (e.g., The time I spent using SFT just slipped away), perceived usability (e.g., I was frustrated while using SFT), aesthetic appeal (e.g., SFT was attractive), and rewarding (e.g., Using SFT was worthwhile).
Each construct includes 3 items (score 3-15) and can be treated as subscales or as a summary score of user engagement (4-60).
An overall engagement score can be calculated by adding all of the items together and dividing by twelve.
Higher scores mean a better outcome.
|
1 month after birth
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R21HD103039 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
National University of SingaporeRecruitingSmoking &Amp; Tobacco CessationSingapore
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedSmoking &Amp; Tobacco CessationUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Sultan Qaboos UniversityCompletedSmoking Cessation | Tobacco Use Cessation | Smoking PreventionOman
-
The University of Hong KongCompletedSmoking Cessation Counseling Ability | Smoking Cessation Counseling PracticeHong Kong
Clinical Trials on SFT 2.0
-
ArkinAmsterdam UMC, location VUmc; Ziekenhuis Amstelland; Meander Medisch Centrum; Sinai... and other collaboratorsCompletedPosttraumatic Stress Disorder (PTSD) | Avoidant Personality Disorder | Dependent Personality Disorder | Obsessive Compulsive Personality DisorderNetherlands
-
Hospital for Special Surgery, New YorkDJO IncorporatedCompletedTotal Hip ArthroplastyUnited States
-
University of Sao PauloCompleted
-
BrainQ Technologies Ltd.Completed
-
Work Life HelpNational Institute on Aging (NIA)CompletedPsychosocial Deprivation | Work-Related Stress | Life-work ImbalanceUnited States
-
Aarhus University HospitalActive, not recruitingPatella DysplasiaDenmark
-
NYU Langone HealthNational Institutes of Health (NIH); Alzheimer's Association; LiteCure LLCActive, not recruitingAlzheimer Disease | Mild Cognitive ImpairmentUnited States
-
ArkinTilburg University; Ggz Oost Brabant; GGZ de Viersprong; Stichting Altrecht GGZ; Stichting...RecruitingSevere Personality DisorderNetherlands
-
Northwestern UniversityOhio State UniversityActive, not recruitingKidney Stone | Ureteral StoneUnited States
-
University of PittsburghNational Institute of Mental Health (NIMH); Kaiser Foundation Research InstituteCompleted